These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms]. Ludeña Carpio C; Madero López L; Barrio Corrales F; Lozano Jiménez C; Martínez Beltrán J; Loza E An Esp Pediatr; 1981 Nov; 15(5):503-6. PubMed ID: 7036809 [No Abstract] [Full Text] [Related]
3. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli. Sklaver AR; Greenman RL; Hoffman TA Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135 [TBL] [Abstract][Full Text] [Related]
4. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis. Nevrekar S; Cunningham KC; Greathouse KM; Panos NG Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis. Hamory B; Ignatiadis P; Sande MA JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564 [No Abstract] [Full Text] [Related]
6. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery. Cook LN; Davis RS; Stover BH Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597 [TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. Wright PF; Kaiser AB; Bowman CM; McKee KT; Trujillo H; McGee ZA J Infect Dis; 1981 Feb; 143(2):141-7. PubMed ID: 7012246 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of cefotaxime in gram-negative meningitis. LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133 [TBL] [Abstract][Full Text] [Related]
9. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms. Kaplan SL; Patrick CC Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430 [TBL] [Abstract][Full Text] [Related]
10. Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series. Tsolaki V; Karvouniaris M; Manoulakas E; Kotlia P; Karadontas V; Fotakopoulos G; Zakynthinos E; Makris D J Crit Care; 2018 Oct; 47():338-341. PubMed ID: 30097260 [TBL] [Abstract][Full Text] [Related]
12. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin. Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802 [TBL] [Abstract][Full Text] [Related]
13. Gram negative bone and joint infection: sixty patients treated with amikacin. Schurman DJ; Wheeler R Clin Orthop Relat Res; 1978; (134):268-74. PubMed ID: 365414 [TBL] [Abstract][Full Text] [Related]
14. [Nosocomial meningitis with dual agents and treatment with intraventricular gentamicin]. Oztoprak N; Celebi G; Baruönü F; Kalayci M Mikrobiyol Bul; 2008 Jul; 42(3):497-501. PubMed ID: 18822895 [TBL] [Abstract][Full Text] [Related]
15. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin. Rubens CE; McGee ZA; Farrar WE J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523 [TBL] [Abstract][Full Text] [Related]
17. Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state. Remeš F; Tomáš R; Jindrák V; Vaniš V; Setlík M J Neurosurg; 2013 Dec; 119(6):1596-602. PubMed ID: 23952688 [TBL] [Abstract][Full Text] [Related]
18. Gentamicin. Clinical and pharmacological studies. Holloway WJ Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081 [No Abstract] [Full Text] [Related]
19. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy. Leonard JM; McGee ZA; Alford RH Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience with amikacin, a new aminoglycoside antibiotic. Theron FP; De Kock MA S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]